ClearPoint Neuro (CLPT) reported a Q1 loss late Wednesday of $0.32 per diluted share, widening from a loss of $0.22 a year earlier.

Three analysts surveyed by FactSet expected a loss of $0.27.

Revenue for the quarter ended March 31 was $12.1 million, up from $8.5 million a year earlier.

Three analysts polled by FactSet expected $12.0 million.

The company expects 2026 revenue of $52 million to $56 million. Three analysts expect $53 million.

Shares of ClearPoint Neuro rose 2.8% in after-hours activity.